Still Taking Ozempic? The Drug Worked — That's What Makes This Hard

Marin & MurphySuper Lawyers® 2014–2024(888) 348-2735

Ozempic (GLP-1) Lawsuit — Free Case Review

Suing the Maker Is Not Suing Your Doctor

The claim is against the manufacturer — your doctor isn't the target. See if your situation fits the current criteria.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.

Did this happen to you — or someone you love?

Start your free case reviewTell us anyway

Answered 24/7 · Free & confidential · No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney's fee is a percentage of the gross recovery, calculated before expenses are deducted.

(888) 348-2735

Partners

Matthew T. Marin & Stefanie A. Murphy

Super Lawyers® honorees · American Association for Justice members

Ozempic inquiries get a personal review — and an honest answer either way, free and without obligation.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state. Do not stop, start, or change any prescribed medication because of anything on this page. Those decisions belong with your prescriber. Attorney Advertising.

Being on a GLP-1 right now does not automatically disqualify you. For the NAION track, a diagnosis made while taking the medication or after stopping it can qualify. For the stomach-injury track, criteria require diagnosis while taking the medication or within about 30 days of stopping — so continuing use is not the problem; the timing of the diagnosis is what gets examined. Whether to stay on or come off a prescription is a medical decision for you and your prescriber, and this page does not give that advice.

A conflict that most legal pages pretend does not exist

A lot of people reading this are in a position nobody writes about: the medication did what it was supposed to do. Blood sugar came down. Weight came off. Something that had not worked in years finally worked. Then something went wrong, and the two facts sit next to each other and refuse to resolve.

You can be glad it worked and still be entitled to know what you were and were not told about the risks. Those positions do not contradict each other, and nothing here asks you to decide that the medication was a mistake.

What continuing use actually does to a claim

Very little on its own. The criteria look not at whether you are currently taking the drug, but at when your diagnosis was made relative to when you were taking it. The two tracks differ.

NAION (sudden optic-nerve vision loss)

The more forgiving of the two on timing. A diagnosis qualifies whether it was made while taking the medication or after stopping, and no cutoff date is stated. Required: an actual NAION diagnosis — not a suspicion, not a symptom — some degree of permanent vision impairment, and brand-name Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound. Generic and compounded products do not meet the brand requirement.

Stomach injuries (gastroparesis or gastric obstruction)

Tighter: the diagnosis must have been made while taking the medication or within about 30 days of stopping. If you are still taking it, that is satisfied by definition for any diagnosis made during use. Also required: brand-name Ozempic, Wegovy, or Rybelsus; gastroparesis confirmed by a gastric emptying study or obstruction confirmed by objective testing; a related ER visit or hospital admission; a diagnosis before December 31, 2024; and an age of 75 or under at intake.

Where people get this wrong in both directions

Some assume that because they never stopped, they cannot have a claim. That is backwards — continuous use makes the timing element easier, not harder.

Others assume they must quit first to be taken seriously. Not true, and not something we would ask. Starting, staying on, adjusting or stopping a GLP-1 are medical decisions that belong with your prescriber: talk to your doctor about the medication, and to us about the records.

What to bring, whatever you decide about the prescription

• The brand name of every GLP-1 you have taken, and whether it came from a retail pharmacy or a compounding pharmacy, telehealth service, or med spa. If unsure, say so rather than guessing.
• Start and stop months and years for each, including if you are still taking it today.
• The month and year of any diagnosis and who made it.
• Whether there was an ER visit or hospital admission, and roughly when.
• Whether you had a gastric emptying study. “I’m not sure what tests I had” is a complete and common answer.
• Pharmacy receipts, pens, boxes and packaging — how brand-name use gets proven.

The honest part

Criteria are screening rules, not laws, and they change. If your dates are close to a line rather than comfortably on one side of it, that is a conversation, not a rejection.

Where the litigation stands: no GLP-1 case has settled and none has been tried. In August 2025 the court overseeing the stomach-injury cases ruled that a gastroparesis claim must be supported by a properly performed gastric emptying study; a Rule 702 hearing there is underway September 14 through 18, 2026. The NAION proceeding, created December 2025, has produced no merits rulings. European regulators concluded in June 2025 that NAION is a very rare side effect of semaglutide medicines. The manufacturers dispute causation in both tracks.

Common questions

Common questions: can you sue?, it’s not about your doctor, is it too late to file?, still on a GLP-1, stopped taking it, switched drugs, calling for a parent, and how compensation works.